Full Text View
Tabular View
No Study Results Posted
Related Studies
A Five-Tier, Phase 2 Open-Label Study of IMC-A12 Administered as a Single Agent
This study is currently recruiting participants.
Study NCT00668148   Information provided by ImClone LLC
First Received: April 25, 2008   Last Updated: November 6, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Rhabdomyosarcoma
Leiomyosarcoma
Adipocytic Sarcoma
Synovial Sarcoma
Additional conditions recognized in this trial
Neuroectodermal Tumors
Neuroectodermal Tumors, Primitive
Neuroectodermal Tumors, Primitive, Peripheral
Sarcoma
Sarcoma, Ewing's
Sarcoma, Synovial
More general conditions related to this trial
Myosarcoma
Neoplasms
Neoplasms by Histologic Type
Neoplasms, Bone Tissue
Neoplasms, Connective and Soft Tissue
Neoplasms, Connective Tissue
Neoplasms, Germ Cell and Embryonal
Neoplasms, Glandular and Epithelial
Neoplasms, Muscle Tissue
Neoplasms, Nerve Tissue
Neoplasms, Neuroepithelial
Osteosarcoma
Interventions listed in this trial
IMC-A12
Sponsors listed in this trial
ImClone LLC


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services